17-63939367-C-CACACATATAT
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_000334.4(SCN4A):c.*1394_*1403dupATATATGTGT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.43 ( 15906 hom., cov: 0)
Exomes 𝑓: 0.13 ( 2 hom. )
Consequence
SCN4A
NM_000334.4 3_prime_UTR
NM_000334.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.130
Genes affected
SCN4A (HGNC:10591): (sodium voltage-gated channel alpha subunit 4) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with 24 transmembrane domains and one or more regulatory beta subunits. They are responsible for the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family. It is expressed in skeletal muscle, and mutations in this gene have been linked to several myotonia and periodic paralysis disorders. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 17-63939367-C-CACACATATAT is Benign according to our data. Variant chr17-63939367-C-CACACATATAT is described in ClinVar as [Benign]. Clinvar id is 324479.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.548 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.431 AC: 65261AN: 151246Hom.: 15902 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
65261
AN:
151246
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.132 AC: 10AN: 76Hom.: 2 Cov.: 0 AF XY: 0.113 AC XY: 7AN XY: 62 show subpopulations
GnomAD4 exome
AF:
AC:
10
AN:
76
Hom.:
Cov.:
0
AF XY:
AC XY:
7
AN XY:
62
show subpopulations
African (AFR)
AF:
AC:
0
AN:
4
American (AMR)
AF:
AC:
0
AN:
4
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
AC:
1
AN:
4
European-Finnish (FIN)
AF:
AC:
1
AN:
4
Middle Eastern (MID)
AF:
AC:
0
AN:
2
European-Non Finnish (NFE)
AF:
AC:
8
AN:
54
Other (OTH)
AF:
AC:
0
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.431 AC: 65289AN: 151362Hom.: 15906 Cov.: 0 AF XY: 0.429 AC XY: 31701AN XY: 73896 show subpopulations
GnomAD4 genome
AF:
AC:
65289
AN:
151362
Hom.:
Cov.:
0
AF XY:
AC XY:
31701
AN XY:
73896
show subpopulations
African (AFR)
AF:
AC:
7932
AN:
41388
American (AMR)
AF:
AC:
6683
AN:
15204
Ashkenazi Jewish (ASJ)
AF:
AC:
1926
AN:
3458
East Asian (EAS)
AF:
AC:
2316
AN:
5084
South Asian (SAS)
AF:
AC:
1845
AN:
4790
European-Finnish (FIN)
AF:
AC:
5460
AN:
10434
Middle Eastern (MID)
AF:
AC:
160
AN:
290
European-Non Finnish (NFE)
AF:
AC:
37431
AN:
67724
Other (OTH)
AF:
AC:
999
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1647
3294
4941
6588
8235
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
1395
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hypokalemic periodic paralysis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Paramyotonia congenita of Von Eulenburg Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Congenital Myasthenic Syndrome, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
May 15, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Familial hyperkalemic periodic paralysis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Potassium-aggravated myotonia Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.